RT Journal Article
SR Electronic
T1 Global projections of lives saved from COVID-19 with universal mask use
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.08.20209510
DO 10.1101/2020.10.08.20209510
A1 Emmanuela Gakidou
A1 David M. Pigott
A1 Christopher E. Troeger
A1 Erin N. Hulland
A1 Robert C. Reiner, Jr
A1 Christopher Adolph
A1 Aleksandr Y. Aravkin
A1 Steven D. Bachmeier
A1 Bree Bang-Jensen
A1 Ryan M. Barber
A1 Catherine Bisignano
A1 Sabina Bloom
A1 Austin Carter
A1 Emma Castro
A1 Suman Chakrabarti
A1 Jhilik Chattopadhyay
A1 Christine Chen
A1 Rebecca M. Cogen
A1 James K. Collins
A1 Emily Combs
A1 Natalie Maria Cormier
A1 Xiaochen Dai
A1 William James Dangel
A1 Amanda Deen
A1 Samuel B. Ewald
A1 Abraham D. Flaxman
A1 Nancy Fullman
A1 Gaorui Guo
A1 Kathryn Hackman
A1 Jiawei He
A1 Nathaniel J. Henry
A1 Casey Johanns
A1 Samantha Leigh Larson
A1 Alice Lazzar-Atwood
A1 Kate E. LeGrand
A1 Haley Lescinsky
A1 Stephen S. Lim
A1 Emily Linebarger
A1 Rafael Lozano
A1 Rui Ma
A1 Beatrice Magistro
A1 Johan C. Månsson
A1 Laurie B. Marczak
A1 Molly K. Miller-Petrie
A1 Ali H. Mokdad
A1 Meghan D. Mooney
A1 Christopher M. Odell
A1 James K. O’Halloran
A1 Samuel M. Ostroff
A1 Maja Pasovic
A1 Disha J. Patel
A1 Louise Penberthy
A1 Rebecca E. Ramshaw
A1 Gregory A. Roth
A1 David H. Shaw
A1 Brittney S. Sheena
A1 Aleksei Sholokhov
A1 Reed J. D. Sorensen
A1 Gianna Sparks
A1 Emma Elizabeth Spurlock
A1 Michelle L. Subart
A1 Ally Walker
A1 Alexandrea Watson
A1 Catherine A. Welgan
A1 Kirsten E. Wiens
A1 Lauren Woyczynski
A1 Liming Xu
A1 Simon I. Hay
A1 Michael Brauer
A1 Theo Vos
A1 Christopher J. L. Murray
A1 IHME COVID-19 Forecasting Team
YR 2020
UL http://medrxiv.org/content/early/2020/11/18/2020.10.08.20209510.abstract
AB BACKGROUND Social distancing mandates (SDM) have reduced health impacts from COVID-19 but also resulted in economic downturns that have led many nations to relax SDM. Until deployment of an efficacious and equitable vaccine, intervention options to reduce COVID-19 mortality and minimize restrictive SDM are sought by society.METHODS A susceptible-exposed-infectious-recovered (SEIR) deterministic transmission model was parameterized with data on reported deaths, cases, and select covariates to predict infections and deaths from COVID-19 through March 01, 2021. We explore three scenarios: a “non-adaptive” scenario where neither mask use or SDM adapt to changing conditions, a “reference” where current national levels of mask use are maintained and SDM reintroduced when deaths rise, and an increase in mask use to 95% coverage levels (“universal mask”). We reviewed published studies to set priors on the magnitude of reduction in transmission through increasing mask use.RESULTS Mask use was estimated at 59.0% of people globally on October 19, 2020. Universal mask use could avert 733,310 deaths (95% UI 385,981 to 1,107,759) between October 27, 2020 and March 01, 2021, the difference between the predicted 2.95 million deaths (95% UI 2.70 to 3.35) in the reference scenario and 2.22 million deaths (95% UI 2.00 to 2.45) in the universal mask scenario over this time period.CONCLUSIONS The cumulative toll of the COVID-19 pandemic could be substantially reduced by the universal adoption of masks before the availability of a vaccine. This low-cost, low-barrier policy, whether customary or mandated, has enormous health benefits with presumed marginal economic costs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Bill & Melinda Gates Foundation and Bloomberg Philanthropies. The funders of the study had no role in study design, data collection, data analysis, data interpretation, writing of the final report, or decision to publish. The corresponding author had full access to all of the data in the study and had final responsibility for the decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We only use data collected by other entities.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available to researchers and where not freely available, information on how to access the data is provided.